Feuerstein Instrumental Enrichment Program for People With Schizophrenia After the First Episode of Psychosis: Protocol for an Open-Label Intervention Study

被引:0
|
作者
Fonseca, Ana Olivia [1 ,2 ]
Gomes, July Silveira [1 ,2 ]
Novaes, Rafael Angulo Condoretti Barros [3 ]
Dias, Cintia Lopes [1 ,2 ]
Rodrigues, Maria Eva de Miranda Alves [1 ]
Gadelha, Ary [1 ,2 ]
Noto, Cristiano [1 ,2 ]
机构
[1] Univ Fed Sao Paulo, Psychiat Dept, Episode Program 1, 241 Rua Major Maragliano,Vila Mariana, BR-04017030 Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Clin Neurosci Lab, Sao Paulo, Brazil
[3] Univ Fed Sao Paulo, Psychobiol Dept, Sao Paulo, Brazil
来源
JMIR RESEARCH PROTOCOLS | 2024年 / 13卷
关键词
schizophrenia; Feuerstein Instrumental Enrichment program; cognitive intervention; functionality; first-episode psychosis; early stages; Feuerstein Instrumental Enrichment; FIE; psychotic disorder; psychotic disorders; neurocognitive deficits; economicburden; cognitive rehabilitation; quality of life; daily living; cognitive assessment; maze task; mental disorder; cognitive deficits; mental health; psychosis; COGNITIVE REMEDIATION; REHABILITATION; METAANALYSIS; 1ST-EPISODE; SYMPTOMS; WORLD;
D O I
10.2196/57031
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Schizophrenia is a disorder associated with neurocognitive deficits that adversely affect daily functioning and impose an economic burden. Cognitive rehabilitation interventions, particularly during the early phases of illness, have been shown to improve cognition, functionality, and quality of life. The Feuerstein Instrumental Enrichment (FIE) program, based on the Mediated Learning Experience and the Structural Cognitive Modifiability theory, has been applied in various disorders, but its applicability in schizophrenia has not yet been clarified. Objective: This study aims to investigate the effects of the FIE program on the functionality of patients with first-episodeschizophrenia. Methods: In total, 17 patients will be recruited for an open-label intervention consisting of twice-weekly sessions for 10 weeks. The primary outcome measure will be changes in the Goal Achievement Scale score. Maze task performance from the Measurementand Treatment Research to Improve Cognition in Schizophrenia (MATRICS) battery will serve as a secondary outcome measure.At the same time, changes in Positive and Negative Syndrome Scale scores and other MATRICS domains will be analyzed asexploratory outcomes. Assessments will be administered before and after the intervention, with a follow-up period of 6 months. Results: This trial was preregistered in The Brazilian Registry of Clinical Trials (RBR-4gzhy4s). By February 2024, 11participants were enrolled in the training. Recruitment is expected to be completed by May 2024. Data analysis will be conductedbetween May and September 2024. The results are expected to be published in January 2025. Conclusions: This study may establish a protocol for the FIE program that uses mediation techniques for individuals in theearly stages of schizophrenia. The results will add to the knowledge about strategies to promote cognitive skills and functionalimpairment in daily life.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] An open-label study of olanzapine in the first episode of schizophrenia in adolescents
    Dabokowska, M
    EUROPEAN PSYCHIATRY, 2002, 17 : 115S - 115S
  • [2] Tolerability and efficacy of aripiprazole in patients with first-episode schizophrenia: An open-label pilot study
    Saha, AR
    Brown, D
    McEvoy, J
    Ali, M
    Abou-Gharbia, N
    Stock, E
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 158 - 158
  • [3] Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: An open-label trial
    Takahashi, Hitoshi
    Kamata, Mitsuhiro
    Yoshida, Keizo
    Ishigooka, Jun
    Higuchi, Hisashi
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (10) : 1577 - 1582
  • [4] Implementing the Latvian Early Intervention Program (LAT-EIP) for Patients With Schizophrenia Spectrum First-Episode Psychosis: Study Protocol
    Berze, Liene
    Civcisa, Sandra
    Krone, Ilona
    Kvartalovs, Dmitrijs
    Kikuste, Sarmite
    Sapele, Inna
    Lazovika, Jelena
    Rancans, Elmars
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [5] THE OPTIMISE STUDY: AMISULPRIDE AND OLANZAPINE FOLLOWED BY OPEN-LABEL TREATMENT WITH CLOZAPINE IN FIRST-EPISODE SCHIZOPHRENIA
    Arango, Celso
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S115 - S115
  • [6] Exploring the Health Status of People with First-Episode Psychosis Enrolled in the Early Intervention in Psychosis Program
    Chee, Gin-Liang
    Wynaden, Dianne
    Heslop, Karen
    ISSUES IN MENTAL HEALTH NURSING, 2020, 42 (01) : 57 - 64
  • [7] Efficacy and safety of paliperidone ER in patients with first episode psychosis: An open-label, prospective, multi-center study
    Chung, Y. -C.
    Park, J. -I.
    Cho, D. -H.
    Hahn, S. -W.
    Han, C.
    Jung, M. H.
    Kim, J. -H.
    Kim, S. -W.
    Lee, K. Y.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 67 - 67
  • [8] A Supervised Exercise Intervention for Youth at Risk for Psychosis: An Open-Label Pilot Study
    Dean, Derek J.
    Bryan, Angela D.
    Newberry, Raeana
    Gupta, Tina
    Carol, Emily
    Mittal, Vijay A.
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (09) : E1167 - +
  • [9] Open-label randomized trial comparing the efficacy and tolerability of quetiapine and olanzapine in first episode psychosis in adolescents
    Parellada, M. J.
    Moreno, D.
    Ruiz-Sancho, A.
    Medina, O.
    Arango, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S377 - S378
  • [10] Discharge destinations for young people with a first episode of psychosis after attending an early intervention for psychosis service
    O'Donoghue, Brian
    Thompson, Andrew
    McGorry, Patrick
    Brown, Ellie
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2023, 57 (10): : 1359 - 1366